Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha Linolenic Acid-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults With Mild Cognitive Impairment: Targeting Cerebrovascular and Blood-brain Barrier Health

NCT07392723 is registered in ClinicalTrials.gov with Michal Schnaider Beeri, Ph.D. as lead sponsor.

NCT NCT07392723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07392723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha Linolenic Acid-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults With Mild Cognitive Impairment: Targeting Cerebrovascular and Blood-brain Barrier Health
Lead sponsor
Michal Schnaider Beeri, Ph.D.
Phase
Phase 2
Overall status
Recruiting
Start date
January 12, 2025
Completion date
October 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, apolipoprotein e, deficiency or defect of, blood-brain barrier, brain aging, cognitive dysfunction, fatty acids, omega-3